InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-37.6%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Shah Rajeev M., Director. Officer active across 3 companies, notably Black Diamond Therapeutics, Inc.. Cumulatively, 5 reports have been logged. Activity tracked since 20 May 2021. The latest transaction was filed on 6 June 2023 (U). Regulator: SEC (Form 4). All data is free.
Declarations5 total
5,914,252 shares@ US$0.91100.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-23-014898:0
20,000 shares0Common StockSEC:0001415889-21-003125:0
20,000 shares0Common StockSEC:0001415889-21-003125
443 shares@ US$24.0150.0% of flowCommon StockSEC:0001104659-21-070583
443 shares@ US$24.010.0063% mcap50.0% of flowCommon StockSEC:0001104659-21-070583:0
5 of 5 declarations
About Shah Rajeev M.
Shah Rajeev M. is a Board Member at Black Diamond Therapeutics, Inc. and Kala Pharmaceuticals, Inc. He contributes to the governance of these companies by participating in strategic decision-making and overseeing operations. His experience in the pharmaceutical sector is an asset for the organizations.
